MoneyWorks4Me

Zydus Lifesciences informs about press release

04 Aug 2022 Evaluate
Zydus Lifesciences has informed about press releases dated August 4, 2022 titled 'Zydus receives final approval from the USFDA for Ivermectin Cream' and 'Zydus receives final approval from the USFDA for Empagliflozin Tablets'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..